维普期刊资源整合服务平台（V6.5）

109篇 您的检索式：作者名="Lorigan"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer显示文摘	Ettinger DS Jotte R Lorigan P		0，，15：	1
2	Randomized phase Ⅱ study of tenozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma 显示文摘	Danson S Lorigan P Arance A	2003	J Clin Oncol2003，21，13：	1
3	Characteristics of women with recurrent molar pregnancies显示文摘	Lorigan P C Sharma S Bright N	2000	Gynecol Oncol2000，78，31：	1
4	Phase Ⅱ trial of sorafenib combined with dacabazine in metastatic melanoma patients (abstract) 显示文摘	Lorigan P Corrie P Chao P	2006	Proc Am Soc Clin Oncol2006，24，：	1
5	No longer an untreatable disease:How targeted and immunotherapies have changed the management of melanoma patients 显示文摘	GIROTTI M R SATURNO G LORIGAN P	2014	Mol Oncol2014，8，6：	1
6	A phase Ⅱ trial with RFS2000 (rubitecan)in patients with advanced non-small cell lung cancer显示文摘	Baka S Ranson M Lorigan P	2005	EurJ Cancer2005，41，11：	1
7	Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta analysis of 18 trials involving 2,621 patients 显示文摘	Ives NJ Stowe RL Lorigan P	2007	J Clin Oncol2007，25，34：	1
8	Phase Ⅲ study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer显示文摘	Soeinski MA Smit EF Lorigan P	2009	Clin Oncol2009，27，28：	1
9	Phase II trial of tremeli- mumab (CP-675,206) in patients with advanced refractory or relapsed melanoma显示文摘	Kirkwood JM Lorigan P Hersey P	2010	Clin Cancer Res2010，16，3：	1
10	Phase I1 pilot study of intravenous high - dose interteron with or without main- tenanee treatment in melanoma at high risk of recurrence 显示文摘	Payne M J Argyropnulou K Lorigan P	2014	J Clin Oneol2014，32，3：	1
11	Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer 显示文摘	Soeinski MA Smit EF Lorigan P	2009	J ClinOncol2009，27，28：	1
12	Current drug treatment guidelines for epithelial ovarian cancer显示文摘	LORIGAN P C CROSBY T COLEMAN R E	1996	Drugs1996，51，4：	1
13	CT and MR imaging of malignant germ cell tumor of the undescended testis显示文摘	Lorigan J G Shirkhoda A Dexeus F H	1989	Urol Radiol1989，11，2：	1
14	Thoracic lymphoma显示文摘	North LB Libshitz HI Lorigan JG	1990	Radiol Clin North Am1990，28，4：	1
15	Phase III study of pemetrexed plus carboplatin compared with eto- poside plus earboplatin in chemotherapy - naive patients with extensive - stage small - cell lung cancer 显示文摘	Smit E F Lorigan P Socinski M A	2009	J Clin Oncol2009，27，28：	1
16	Phase Ⅱ trial of tremelimumab (CP-675,206) in patients with advanced re- fractory or relapsed melanoma 显示文摘	Kirkwood JM Lorigan P Hersey P	2010	Clin Cancer Res2010，16，3：	1
17	Randomized phase II study(EORTC08062)ofamrubicin as single agent or in combination withcisplatin versus etoposide-cisplatin as first-line treatment in patients(pts)with extensive disease small cell lung Cancer(ED SCLC)显示文摘	Brien M Jassem J Lorigan P	2010	J Clin Oncol2010，28，15：	1
18	Thoracic radiotherapy for limited-stage small-cell lung cancer:controversies and future developments显示文摘	Faivre-Finn C Lee LW Lorigan P	2005	Clin Oncoz(R Coll Radio1)2005，17，8：	1
19	TNF-alpha increases human melanoma cell invasion and migration in vitro:the role of proteolytic enzymes 显示文摘	Katerinaki E Evans GS Lorigan PC	2003	Br J Cancer2003，89，6：	1
20	The radiologic manifestations of alveolar soft - part sarcoma 显示文摘	Lorigan JGM O' keefe FN Evans HL	1989	A JR1989，153，8：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示